Royalty Pharma RPRX Earnings yield
Earnings yield at other companies
Other financials
Where this comes from
Calculated from Royalty Pharma’s reported figures.
Based on trailing twelve months.
The official record: Royalty Pharma’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about Royalty Pharma's earnings yield.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Royalty Pharma's earnings yield?
- Royalty Pharma (RPRX) reported earnings yield of 4% in Q1 2026.
- How has Royalty Pharma's earnings yield changed year-over-year?
- Royalty Pharma's earnings yield decreased by 50.3% year-over-year, from 8.1% to 4%.
- What is the long-term trend for Royalty Pharma's earnings yield?
- Over 4 years (2020 to 2025), Royalty Pharma's earnings yield has grown at a -14.5% compound annual growth rate (CAGR), from 8.8% to 4.7%.
- What does earnings yield mean?
- The company's annual profit as a percentage of its market price — the flip side of the P/E.
- How do you interpret earnings yield?
- Higher means more earnings per dollar invested. Easy to compare directly against bond yields to judge the relative attractiveness of equity.
- How does earnings yield compare across companies?
- Comparable across profitable companies and against fixed-income yields; undefined when earnings are negative.